Analytical Data
-
Gene name
C17orf50
- Application
-
Alternative Names
C17orf50Uncharacterized Protein C17orf50
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8WW18
-
Expression Region
1-174aa
-
AA Sequence
MDKHGVKTPL WKKETEELRA EDAEQEEGKE GSEDEDEDNQ RPLEDSATEG EEPPRVAEEG EGRERRSVSY CPLRQESSTQ QVALLRRADS GFWGWLGPLA LLGGLTAPTD RKRSLPEEPC VLEIRRRPPR RGGCACCELL FCKKCRSLHS HPAYVAHCVL DHPDLGKAGA AGNS
-
Molecular Weight
45.54 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C17orf50, also known as chromosome 17 open reading frame 50, is a gene located on chromosome 17 that has garnered attention for its potential role in various biological processes. Research into C17orf50 is driven by its expression patterns in diverse tissues and its possible involvement in diseases, including cancer and neurodegenerative disorders. Recent studies suggest that C17orf50 may play a role in cellular signaling pathways, although its exact biological function remains largely unexplored. The characterization of recombinant C17orf50 protein is crucial for elucidating its role and mechanisms at the molecular level. By expressing and purifying this protein, researchers aim to investigate its interactions with other cellular proteins and analyze its structural properties. This could provide insights into how C17orf50 contributes to cellular functions and its implications in disease. Furthermore, studying the recombinant form of the protein paves the way for the development of targeted therapeutic strategies. Understanding the biological significance of C17orf50 through recombinant protein studies may ultimately unveil new avenues for diagnosis and treatment in conditions linked to its dysregulation. Thus, investing in research on C17orf50 is essential for unraveling its contributions to health and disease.
